Disorders of sex development (DSD) are phenotypically heterogeneous, ranging from minor genital malformations (hypospadias, cryptorchidism, hypertrophy of the clitoris) to genital ambiguity. In the aggregate, DSD have an estimated incidence of about 1%. DSD can result in severe consequences for behavioral health, fertility, cancer risk and quality of life. For families, the birth of a child with a DSD, and the accompanying uncertainty about future psychological and sexual development, is believed to be extraordinarily stressful. Recently, the debate over clinical management of DSD, in particular gender assignment and genital surgery, has intensified;yet the scientific data on patient outcomes have remained very incomplete. Major obstacles to optimal clinical management of DSD include gaps in understanding of pathophysiology, impeding precise diagnostic categorization, along with the absence of prospective longitudinal studies of health and quality of life outcomes. This proposal delivers a platform for hypothesis-based research on the mechanisms of sex development and evidence-based care for patients and families affected by DSD.
Aim 1 identifies novel genetic mechanisms of sex development and improves understanding of the pathophysiology and molecular diagnosis of DSD by a step-wise approach of specific DNA capture and sequencing, analysis of copy number variants, and identification of novel candidate genes for DSD.
Aim 2 delivers standardized tools for reliable phenotypic descriptions across multiple study sites and investigators, including radiological, biochemical, histological evaluations and descriptions of genital phenotype and post- surgical appearance and function, facilitating interpretation of genetic, gender, and quality of life outcomes Aim 3 identifies short and medium-term outcomes by delivering a comprehensive psychosocial and health-related quality of life assessment battery using psychometrically robust measures suitable for use in routine clinical care, a necessary step leading to evidence-based psychosocial treatment protocols.
Aim 4 builds a sustainable research infrastructure and ensures rapid translation of new evidence into ongoing clinical practice by integrating standardized DSD diagnostic and treatment protocols and fostering the transfer of best practices in healthcare delivery across network sites. This registry provides the analytic platform by which data are collected, analyzed, and shared among researchers and sites, while a collaborative network will supply the foundation for multidisciplinary basic, clinical, and translational research. This unique combination of genetic, phenotypic and psychosocial approaches will transform participating sites into self-sustaining DSD "centers of excellence" for clinical care along with the added value of a registry serving as a critical resource for hypothesis-driven research.

Public Health Relevance

One of the most defining moments of our lives is when, in the womb, we embark on a male or female path. Disruption of typical male or female development, whether mild or severe, results in Disorders of Sex Development (DSD), which occur quite frequently, in about 1% of the human population. DSD are extremely stressful for parents and, as they grow older, the affected person and are often accompanied by additional medical and psychological problems;yet little is known about the causes of DSD and what healthcare teams should do in the short and long term. We propose to design a way to learn about the genetic causes and the psychological consequences of DSD, and to use these data to provide healthcare teams with procedures to evaluate and improve care for these patients and their families.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
3R01HD068138-03S1
Application #
8646162
Study Section
Special Emphasis Panel (ZRG1 (02))
Program Officer
Taymans, Susan
Project Start
2011-09-26
Project End
2016-06-30
Budget Start
2013-09-06
Budget End
2014-06-30
Support Year
3
Fiscal Year
2013
Total Cost
$78,400
Indirect Cost
$13,500
Name
University of California Los Angeles
Department
Genetics
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Hanauer, David A; Gardner, Melissa; Sandberg, David E (2014) Unbiased identification of patients with disorders of sex development. PLoS One 9:e108702
Ha, Nathan Q; Dworkin, Shari L; Martínez-Patiño, María José et al. (2014) Hurdling over sex? Sport, science, and equity. Arch Sex Behav 43:1035-42
Caburet, Sandrine; Arboleda, Valerie A; Llano, Elena et al. (2014) Mutant cohesin in premature ovarian failure. N Engl J Med 370:943-9
Gomez-Lobo, Veronica (2014) Multidisciplinary care for individuals with disorders of sex development. Curr Opin Obstet Gynecol 26:366-71
Akhavan, Ardavan; Merguerian, Paul A; Grady, Richard W et al. (2014) Digital photographic measurement in hypospadias: validation and comparison to intraoperative measurement. J Pediatr Urol 10:312-6
Baratz, Arlene B; Sharp, Melissa K; Sandberg, David E (2014) Disorders of sex development peer support. Endocr Dev 27:99-112
Baxter, Ruth M; Vilain, Eric (2013) Translational genetics for diagnosis of human disorders of sex development. Annu Rev Genomics Hum Genet 14:371-92
Arboleda, V A; Lee, H; Sanchez, F J et al. (2013) Targeted massively parallel sequencing provides comprehensive genetic diagnosis for patients with disorders of sex development. Clin Genet 83:35-43
Hennekam, Raoul C M; Allanson, Judith E; Biesecker, Leslie G et al. (2013) Elements of morphology: standard terminology for the external genitalia. Am J Med Genet A 161:1238-63
Sanchez, Francisco J; Martinez-Patino, Maria Jose; Vilain, Eric (2013) The new policy on hyperandrogenism in elite female athletes is not about "sex testing". J Sex Res 50:112-5